Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication

Nowadays, nanotechnology is revolutionizing the approaches to different fields from manufacture to health. Carbon nanotubes (CNTs) as promising candidates in nanomedicine have great potentials in developing novel entities for central nervous system pathologies, due to their excellent physicochemical...

Full description

Bibliographic Details
Main Authors: Chenyang Xiang, Yuxuan Zhang, Weisheng Guo, Xing-Jie Liang
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Acta Pharmaceutica Sinica B
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383519306069
_version_ 1828756590493171712
author Chenyang Xiang
Yuxuan Zhang
Weisheng Guo
Xing-Jie Liang
author_facet Chenyang Xiang
Yuxuan Zhang
Weisheng Guo
Xing-Jie Liang
author_sort Chenyang Xiang
collection DOAJ
description Nowadays, nanotechnology is revolutionizing the approaches to different fields from manufacture to health. Carbon nanotubes (CNTs) as promising candidates in nanomedicine have great potentials in developing novel entities for central nervous system pathologies, due to their excellent physicochemical properties and ability to interface with neurons and neuronal circuits. However, most of the studies mainly focused on the drug delivery and bioimaging applications of CNTs, while neglect their application prospects as therapeutic drugs themselves. At present, the relevant reviews are not available yet. Herein we summarized the latest advances on the biomedical and therapeutic applications of CNTs in vitro and in vivo for neurological diseases treatments as inherent therapeutic drugs. The biological mechanisms of CNTs-mediated bio-medical effects and potential toxicity of CNTs were also intensely discussed. It is expected that CNTs will exploit further neurological applications on disease therapy in the near future. Key words: Carbon nanotubes, Nervous system diseases, Drug delivery, Therapeutic drug, Inherent medication, Toxicity
first_indexed 2024-12-10T23:18:53Z
format Article
id doaj.art-5dbcef5b03344b69b3e0dab3ef6934c3
institution Directory Open Access Journal
issn 2211-3835
language English
last_indexed 2024-12-10T23:18:53Z
publishDate 2020-02-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj.art-5dbcef5b03344b69b3e0dab3ef6934c32022-12-22T01:29:46ZengElsevierActa Pharmaceutica Sinica B2211-38352020-02-01102239248Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medicationChenyang Xiang0Yuxuan Zhang1Weisheng Guo2Xing-Jie Liang3Translational Medicine Center, Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, ChinaCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, ChinaTranslational Medicine Center, Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China; Corresponding authors.Translational Medicine Center, Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China; Corresponding authors.Nowadays, nanotechnology is revolutionizing the approaches to different fields from manufacture to health. Carbon nanotubes (CNTs) as promising candidates in nanomedicine have great potentials in developing novel entities for central nervous system pathologies, due to their excellent physicochemical properties and ability to interface with neurons and neuronal circuits. However, most of the studies mainly focused on the drug delivery and bioimaging applications of CNTs, while neglect their application prospects as therapeutic drugs themselves. At present, the relevant reviews are not available yet. Herein we summarized the latest advances on the biomedical and therapeutic applications of CNTs in vitro and in vivo for neurological diseases treatments as inherent therapeutic drugs. The biological mechanisms of CNTs-mediated bio-medical effects and potential toxicity of CNTs were also intensely discussed. It is expected that CNTs will exploit further neurological applications on disease therapy in the near future. Key words: Carbon nanotubes, Nervous system diseases, Drug delivery, Therapeutic drug, Inherent medication, Toxicityhttp://www.sciencedirect.com/science/article/pii/S2211383519306069
spellingShingle Chenyang Xiang
Yuxuan Zhang
Weisheng Guo
Xing-Jie Liang
Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
Acta Pharmaceutica Sinica B
title Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
title_full Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
title_fullStr Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
title_full_unstemmed Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
title_short Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
title_sort biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
url http://www.sciencedirect.com/science/article/pii/S2211383519306069
work_keys_str_mv AT chenyangxiang biomimeticcarbonnanotubesforneurologicaldiseasetherapeuticsasinherentmedication
AT yuxuanzhang biomimeticcarbonnanotubesforneurologicaldiseasetherapeuticsasinherentmedication
AT weishengguo biomimeticcarbonnanotubesforneurologicaldiseasetherapeuticsasinherentmedication
AT xingjieliang biomimeticcarbonnanotubesforneurologicaldiseasetherapeuticsasinherentmedication